引用本文:胡邀时(综述),曾志羽(审校).同型半胱氨酸与常见临床疾病关系的研究进展[J].中国临床新医学,2017,10(8):811-815.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 67次   下载 107 本文二维码信息
码上扫一扫!
分享到: 微信 更多
同型半胱氨酸与常见临床疾病关系的研究进展
胡邀时(综述),曾志羽(审校)
530021 南宁,广西医科大学(胡邀时);530021 南宁,广西医科大学第一附属医院老年心血管内科(曾志羽)
摘要:
[摘要] 近年来,同型半胱氨酸(Hcy)与相关疾病的病理生理机制及其作为治疗靶点、预后评估的研究成为一大热点。随着研究的深入,尽管目前Hcy的致病机理尚不十分明了,但Hcy是一种血管损伤性氨基酸这一提法已得到普遍认可。该文对Hcy与主要常见临床疾病的关系及大致致病机理作一综述。
关键词:  同型半胱氨酸  临床疾病  致病机理  研究进展
DOI:10.3969/j.issn.1674-3806.2017.08.32
分类号:R 54
基金项目:
Research progress of the relationship between homocysteine and common clinical diseases
HU Yao-shi, ZENG Zhi-yu
Research progress of the relationship between homocysteine and common clinical diseases
Abstract:
[Abstract] Recently, homocysteine(Hcy) has become a hotspot on the research fields of pathophysiology of related diseases, the targeted treatment and prognosis evaluation. With the development of the researches, although the pathogenesis of Hcy is not yet clear, it has been generally recognized that Hcy is a amino acid that can injury the blood vessels. In this paper, we summarize the relationship between Hcy and the main clinical common diseases as well as the general pathogenesis.
Key words:  Homocysteine(Hcy)  Clinical diseases  Pathogenesis  Research progress